[1]
Muresanu, H. 2016. Benefits of intermittent/continuous androgen deprivation in patients with advanced prostate cancer. Medicine and Pharmacy Reports. 89, 3 (Jul. 2016), 419-422. DOI:https://doi.org/10.15386/cjmed-594.